SARTORIUS STED BIO (EPA:DIM) | WebDisclosure

Basculer en Français

9480	Companies
185543	Keywords
117939	Articles
99384	Press releases

Home
Companies
SARTORIUS STED BIO

PRESS RELEASE

published on 05/17/2024 at 19:32, 1 year 6 months ago

Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast
Sartorius Stedim Biotech presented its business strategy and goals during Capital Markets Day, reaffirming its 2024 forecast and medium-term ambitions up to 2028. Links to presentation and webcast provided for broad access

Business Strategy Webcast Forecast Sartorius Stedim Biotech Capital Markets Day
BRIEF

published on 05/02/2024 at 15:39, 1 year 7 months ago

Sartorius Stedim Biotech Announces Share and Voting Rights Update

Share Capital Voting Rights Financial News Corporate Governance Sartorius Stedim Biotech
BRIEF

published on 05/02/2024 at 15:39, 1 year 7 months ago

Sartorius Stedim Biotech annonce une mise à jour des actions et des droits de vote

Gouvernance D'Entreprise Droit De Vote Partage Le Capital Sartorius Stedim Biotechnologie Actualités Financières
PRESS RELEASE

published on 05/02/2024 at 15:34, 1 year 7 months ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares the number of shares and voting rights comprising the issued capital as of April 30, 2024

Voting Rights Shares Sartorius Stedim Biotech SA Issued Capital French Regulatory News
PRESS RELEASE

published on 05/02/2024 at 15:34, 1 year 7 months ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Sartorius Stedim Biotech SA announces the total number of shares and voting rights. Regulatory information according to AMF rules

Déclaration Droits De Vote Capital Social Actions Sartorius Stedim Biotech SA
BRIEF

published on 04/18/2024 at 07:07, 1 year 7 months ago

Sartorius Stedim Biotech dévoile ses résultats du premier trimestre 2024

Résultats Financiers Marché Global Biopharmaceutique Prise De Commandes Projections Économiques
BRIEF

published on 04/18/2024 at 07:07, 1 year 7 months ago

Sartorius Stedim Biotech reveals its results for the first quarter of 2024

Financial Results Biopharmaceutical Global Market Taking Orders Economic Projections
PRESS RELEASE

published on 04/18/2024 at 07:02, 1 year 7 months ago

Sartorius Stedim Biotech publie ses résultats non audités pour le premier trimestre 2024
Sartorius Stedim Biotech publie ses résultats non audités pour le premier trimestre 2024 avec un chiffre d'affaires en baisse de 9,4%, des prises de commandes en progression et des prévisions confirmées malgré l'incertitude mondiale

Chiffre D'affaires Sartorius Stedim Biotech Prises De Commandes Résultat Trimestriel Prévisions
PRESS RELEASE

published on 04/18/2024 at 07:02, 1 year 7 months ago

Sartorius Stedim Biotech publishes unaudited first quarter results for 2024
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024, showing sales revenue of 667 million euros and order intake up 13.9 percent. Full-year outlook confirmed amidst global uncertainties

Order Intake Sartorius Stedim Biotech Sales Revenue First Quarter Results Full-year Outlook
BRIEF

published on 04/02/2024 at 15:40, 1 year 8 months ago

Sartorius Stedim Biotech annonce sa structure en capital et droits de vote pour Mars 2024

Droits De Vote Capital Social Actions Sartorius Stedim Biotech Transparence

Accesswire

Published on 12/05/2025 at 20:25, 44 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 54 minutes ago

When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 1 hour 19 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 49 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 2 hours 24 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 2 hours 11 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 2 hours 43 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 2 hours 54 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 3 hours 17 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 3 hours 23 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 3 hours 51 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 51 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 58 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 58 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 7 hours 11 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE